ロード中...

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

BACKGROUND: The addition of hypoxia modifiers carbogen and nicotinamide (CON) to radiotherapy (RT) improved overall survival (OS) in bladder cancer patients in the BCON phase III clinical trial. We investigate whether expression of hsa-miR-210 in BCON patient samples reflects hypoxia and predicts be...

詳細記述

保存先:
書誌詳細
出版年:Br J Cancer
主要な著者: Irlam-Jones, J J, Eustace, A, Denley, H, Choudhury, A, Harris, A L, Hoskin, P J, West, C M L
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4997544/
https://ncbi.nlm.nih.gov/pubmed/27441495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.218
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!